Antenatal Screening for Down Syndrome Using Serum Placental Growth Factor with the Combined, Quadruple, Serum Integrated and Integrated Tests

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  Wald, Nicholas J ^a   Bestwick, Jonathan P ^a   George, Lynne M ^a   Huttly, Wayne J ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; CHORIONIC GONADOTROPIN BETA SUBUNIT; ESTRIOL; INHIBIN A; PLACENTAL GROWTH FACTOR; PREGNANCY ASSOCIATED PLASMA PROTEIN A;

ADULT; ARTICLE; BLOOD SAMPLING; CASE CONTROL STUDY; CONTROLLED STUDY; DOWN SYNDROME; FEMALE; FETUS ECHOGRAPHY; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HUMAN; MAJOR CLINICAL STUDY; MATERNAL BLOOD; MONTE CARLO METHOD; NUCHAL TRANSLUCENCY MEASUREMENT; PRENATAL DIAGNOSIS; SCREENING TEST; SECOND TRIMESTER PREGNANCY; STORAGE TEMPERATURE;

ADULT; DOWN SYNDROME; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; MONTE CARLO METHOD; PREGNANCY; PREGNANCY PROTEINS; PRENATAL DIAGNOSIS; STATISTICS AS TOPIC;

EID: 84867047832     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0046955     Document Type: Article

References (19)

1. Akolekar R, Syngelaki A, Sarquis R, Zvanca M, Nicolaieds KH, (2011) Prediction of early, intermediate and late pre-eclampsia from maternal factors, biophysical and biochemical markers at 11-13 weeks. Prenat Diagn 31: 66-74.
2. Wald NJ, Bestwick JP, George LM, Wu T, Morris JK, (2012) Screening for pre-eclampsia using serum placental growth factor and endoglin measurement with Down's syndrome Quadruple test markers. J Med Screen 19: 60-67.
3. Koster MPH, Wortelboer EJ, Stoutenbeek P, Visser GHA, Schielen PCJI, (2011) Modeling Down syndrome screening performance using first-trimester serum markers. Ultrasound Obstet Gynecol 38: 134-139.
4. Cowans NJ, Stamatopoulou A, Spencer K, (2010) First trimester maternal serum placental growth factor in trisomy 21 pregnancies. Prenat Diagn 30: 449-453.
5. Zaragoza E, Akolekar R, Poon LCY, Pepes S, Nicolaides KH, (2009) Maternal serum placental growth factor at 11-13 weeks in chromosomally abnormal pregnancies. Ultrasound Obstet Gynecol 33: 382-386.
6. Pandya P, Wright D, Syngelaki A, Akolekar R, Nicolaides KH, (2012) Maternal serum placental growth factor in prospective screening for aneuploidies at 8-13 weeks' gestation. Fetal Diagn Ther 31: 87-93.
7. Spencer K, Liao AW, Ong CYT, Geerts L, Nicolaides KH, (2001) First trimester maternal serum placenta growth factor (PlGF) concentrations in pregnancies with fetal trisomy 21 or trisomy 18. Prenat Diagn 21: 718-722.
8. Debieve F, Moiset A, Thomas K, Pampfer S, Hubinont C, (2001) Vascular endothelial growth factor and placental growth factor concentrations in Down's syndrome and control pregnancies. Molecular Human Reproduction 7: 765-770.
9. Su YN, Hsu JJ, Lee CN, Cheng WF, Kung CCS, et al. (2002) Raised maternal serum placenta growth factor concentration during the second trimester is associated with Down syndrome. Prenat Diagn 22: 8-12.
10. Lambert-Messerlian GM, Canick JA, (2004) Placenta growth factor levels in second-trimester maternal serum in Down syndrome pregnancy and in the prediction of preeclampsia. Prenat Diagn 24: 876-880.
11. Morris JK, Wald NJ, (2005) Graphical presentation of distributions of risk in screening. J Med Screen 12: 155-160.
12. Wald NJ, Rodeck C, Hackshaw AK, Walters J, Chitty L, et al. (2003) First and Second trimester Antenatal screening for Down's syndrome: the results of the Serum, Urine and Ultrasound Screening Study (SURUSS). J Med Screen 10: 56-104.
13. Wald N, Rodeck C, Rudnicka A, Hackshaw A, (2004) Nuchal translucency and gestational age. Prenat Diagn 24: 150-1.
14. Wald NJ, Rodeck C, Hackshaw AK, Walters J, Chitty L, et al. (2006B) Correction to the SURUSS report. J Med Screen 13: 51-52.
15. Bestwick JP, Huttly WJ, Wald NJ, (2010) Distribution of nuchal translucency in antenatal screening for Down's syndrome. J Med Screen 17: 8-12.
16. Office for National Statistics 2008. Birth Statistics Series FM1 Numbers 35-37. HMSO: London, 2006, 2007, 2008.
17. Morris JK, Mutton DE, Alberman E, (2002) Revised estimates of the maternal age specific live birth prevalence of Down's syndrome. J Med Screen 9: 2-6.
18. Morris JK, Wald NJ, Mutton DE, Alberman E, (2003) Comparison of models of maternal age-specific risk for Down syndrome live births. Prenat Diagn 23: 252-8.
19. Morris JK, Wald NJ, Watt HC, (1999) Fetal loss in Down syndrome pregnancies. Prenat Diagn 19: 142-145.